Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 03-Nov-2022 titled Alembic Pharmaceuticals announces its second injectable product approval from its General Sterile Facility – Final Approval for Ketorolac……
| Subscribe To Our Free Newsletter |
